Search

Your search keyword '"Rizvi, H."' showing total 14 results

Search Constraints

Start Over You searched for: Author "Rizvi, H." Remove constraint Author: "Rizvi, H." Journal annals of oncology Remove constraint Journal: annals of oncology
Sorry, I don't understand your search. ×
14 results on '"Rizvi, H."'

Search Results

2. COVID-19 in patients with lung cancer

4. Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

6. EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

11. Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients

12. LKB1 loss is a novel genomic predictor of de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma

13. 1407P - Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients

Catalog

Books, media, physical & digital resources